Viewing Study NCT05563961


Ignite Creation Date: 2025-12-24 @ 12:00 PM
Ignite Modification Date: 2026-04-28 @ 8:02 PM
Study NCT ID: NCT05563961
Status: RECRUITING
Last Update Posted: 2024-03-27
First Post: 2022-09-27
Is Gene Therapy: True
Has Adverse Events: False

Brief Title: A Partial Randomized, Single-blind or Open-label, Dose-escalation With Multiple-dose Design Study to Evaluate the Pharmacokinetics of Acetaminophen and Its Toxic Metabolites With Panadol® and SafeTynadol® in Healthy Volunteers
Sponsor: Sinew Pharma Inc.
Organization:

Conditions & Keywords Data

Conditions:

Conditions

Condition Brief Condition Text View
None Hepatitis View
None Pharmacology View
Keywords:

Keywords

Keyword Brief Keyword Text View
None acetaminophen View
None acute liver failure View